The Genitourinary Cancer Channel

Explore the latest updates, including expert interviews and features

Latest videos VJSessions Subtypes Topics Conferences Features Editorial Board

Welcome to the Genitourinary (GU) Cancer Channel!

Explore the latest updates presented at major international congresses in the form of video interviews, podcasts and roundtable discussions featuring members of our expert Editorial Board.

Exciting advances are being made in the field of genitourinary cancer, including checkpoint inhibitor treatments, new non-steroidal anti-androgens, chemoimmunotherapy combinations and predictive biomarkers.

GU Cancer Videos by Subtype

Prostate Cancer
Bladder Cancer
Kidney Cancer
Testicular Cancer
Penile Cancer
1:32
Combining antigen-specific vaccination and targeted radionuclide therapy in a murine prostate model
Douglas G. McNeel • 12 Nov 2021
0:56
Vaccines are a promising direction for prostate cancer immunotherapy
Douglas G. McNeel • 12 Nov 2021
1:30
Asessing the pTVG-HP Plasmid DNA vaccine in patients with mCRPC
Douglas G. McNeel • 12 Nov 2021
1:05
Combining a DNA vaccine with pembrolizumab for mCRPC
Douglas G. McNeel • 12 Nov 2021
View All Videos
1:40
Treating metastatic solid tumors and urothelial carcinoma with the oral AHR inhibitor, IK-175
Jason Luke • 14 Nov 2021
2:10
Highlights from PROSCA/BLADDR 2021
Robert Jones • 15 Oct 2021
2:30
UTUC and bladder carcinoma: are similarities greater than differences?
Eva Compérat • 19 Oct 2021
2:07
Pathologists perpsectives on unmet needs in bladder cancer
Eva Compérat • 19 Oct 2021
View All Videos
0:48
Clinical activity of cabozantinib in patients with RCC with brain metastases
Hannah E. Dzimitrowicz • 13 Nov 2021
2:13
COVID-19 vaccination in patients with RCC and melanoma treated with immune checkpoint inhibitors
Hannah E. Dzimitrowicz • 13 Nov 2021
5:28
Importance of real-world data in clinical trials
Janet E. Brown • 19 Sep 2021
2:21
PRISM: importance of investigating the scheduling of treatment regimens for RCC
Janet E. Brown • 19 Sep 2021
View All Videos
7:05
TRISST: MRI versus FDG-PET-CT for the treatment of testicular cancer
Tahlita Zuiverloon • 15 Jul 2021
3:40
Surgery in metastatic germ cell tumors to reduce disease burden and improve long-term outcomes
Peter Albers • 8 Jul 2021
3:34
Benefits of circulating miRNAs for follow-up of patients with seminoma
Matthew Murray • 1 Jul 2021
1:12
miR-371a-3p microRNA panel alone is sufficient for diagnosis and monitoring
Matthew Murray • 1 Jul 2021
View All Videos
5:44
Long-term outcomes of DSNB for cN0 penile cancer
Edoardo Pozzi • 10 Jul 2021
2:06
c-MET receptor-targeted fluorescence for image-guided surgery in PSCC
Hielke-Martijn De Vries • 7 Jul 2021
3:14
Factors impacting additional tumour-bearing lymph nodes at completion ILND after positive DSNB
Hielke-Martijn De Vries • 7 Jul 2021
1:28
Risk factor analysis of complications after sentinel node biopsy for penile cancer
Hielke-Martijn De Vries • 7 Jul 2021
View All Videos

Topics

Trial Updates
Molecular Profiling
Immuno-Oncology
Diagnosis
Imaging
1:57
Results from Phase I/II study of DS-7300a in advanced solid tumors
Melissa Johnson • 6 Oct 2021
7:34
New agents and novel trials in advanced UC
Petros Grivas • 19 Oct 2021
4:17
PROOF 302: adjuvant infigratinib in FGFR3-mutant invasive UC
Petros Grivas • 19 Oct 2021
1:09
ctDNA MRD as a biomarker for solid tumors
Aadel Chaudhuri • 20 Oct 2021
View All Videos
7:34
New agents and novel trials in advanced UC
Petros Grivas • 19 Oct 2021
1:16
Germline testing in urothelial cancer
Petros Grivas • 19 Oct 2021
4:16
Is ADT alone for patients with mHSPC appropriate?
Robert Jones • 15 Oct 2021
2:30
UTUC and bladder carcinoma: are similarities greater than differences?
Eva Compérat • 19 Oct 2021
View All Videos
2:13
COVID-19 vaccination in patients with RCC and melanoma treated with immune checkpoint inhibitors
Hannah E. Dzimitrowicz • 13 Nov 2021
0:56
Vaccines are a promising direction for prostate cancer immunotherapy
Douglas G. McNeel • 12 Nov 2021
1:32
Combining antigen-specific vaccination and targeted radionuclide therapy in a murine prostate model
Douglas G. McNeel • 12 Nov 2021
1:40
Treating metastatic solid tumors and urothelial carcinoma with the oral AHR inhibitor, IK-175
Jason Luke • 14 Nov 2021
View All Videos
1:03
Latest developments in radiopharmaceutical therapies
Ian A. Wilson • 12 Nov 2021
1:09
ctDNA MRD as a biomarker for solid tumors
Aadel Chaudhuri • 20 Oct 2021
3:58
Liquid biopsy for the diagnosis and treatment of bladder cancer
Aadel Chaudhuri • 20 Oct 2021
3:50
Detection and risk stratification of localized prostate cancer
Eugene Shenderov • 17 Sep 2021
View All Videos
4:09
PSMA PET-CT scan and treatments for patients with cN1 prostate cancer
Silke Gillessen • 7 Sep 2021
3:50
Detection and risk stratification of localized prostate cancer
Eugene Shenderov • 17 Sep 2021
4:54
MGC018 in patients with advanced solid tumors
Eugene Shenderov • 17 Sep 2021
7:05
TRISST: MRI versus FDG-PET-CT for the treatment of testicular cancer
Tahlita Zuiverloon • 15 Jul 2021
View All Videos

Conferences

ESMO 2021
EAU 2021
ASCO 2021
AACR 2021
GU Cancers 2021
PROSCA/BLADDR 2020
3:45
Impacts of COVID-19 infection on patients with urological cancers undergoing surgery
Chuanyu Gao • 7 Jul 2021
3:04
Benefits of T1 substaging for NMIBC
Christiaan De Jong • 21 Jul 2021
4:19
Novel biomarkers for outcomes identified in BCG-treated T1HG bladder cancer
Christiaan De Jong • 21 Jul 2021
3:27
Improving anti-PD-1/PD-L1 therapy for localized bladder cancer
Christiaan De Jong • 21 Jul 2021
View All Videos
4:42
PSMA-targeted imaging with 18F-DCFPyL-PET/CT in patients with prostate cancer
Frédéric Pouliot • 4 Jun 2021
4:45
PrE0807: neoadjuvant nivolumab/lirilumab in cisplatin ineligible patients with MIBC
Petros Grivas • 11 Jun 2021
5:49
JAVELIN Bladder 100 trial updates from ASCO 2021
Petros Grivas • 11 Jun 2021
10:12
Trial updates in prostate cancer from ASCO 2021: VISION, PEACE1, & SWOG S1216
Pedro Barata • 8 Jun 2021
View All Videos
3:07
PSMA dRT: PSMA PET/CT before radiotherapy in prostate cancer
Jeremie Calais • 22 Apr 2021
6:49
RAMP: Phase Ib study of rucaparib & enzalutamide in mCRPC
Arpit Rao • 19 Apr 2021
3:53
Upcoming advances in prostate cancer: PARPi, CDK4/6, lutetium PSMA therapy & CAR-T approaches
Arpit Rao • 19 Apr 2021
4:38
Clinical utility of liquid biopsies in prostate cancer
Arpit Rao • 19 Apr 2021
View All Videos
1:50
Current treatment landscape of seminoma
Siamak Daneshmand • 18 Feb 2021
3:05
CA 125, CA19-9 and CEA: tumor markers in bladder cancer
Siamak Daneshmand • 18 Feb 2021
3:18
SEMS: surgery as first-line therapy for seminoma
Siamak Daneshmand • 18 Feb 2021
3:43
The history of biomarkers in the treatment of prostate cancer
Howard Scher • 18 Feb 2021
View All Videos
0:53
Immunotherapy in prostate cancer
Emmanuel Seront • 7 Oct 2020
1:35
Unmet needs in mHSPC
Ursula Vogl • 7 Oct 2020
1:29
Genomic testing in prostate cancer
Emmanuel Seront • 7 Oct 2020
0:38
Second-line treatment of mHSPC
Ursula Vogl • 7 Oct 2020
View All Videos

The GU Channel on VJOncology is supported by a grant from Pfizer Inc and Merck KGaA. The supporters have no influence over the production of the content.

If you are interested in becoming a supporter of The Genitourinary (GU) Cancer Channel, please contact us

VJOncology VJOncology is intended for Healthcare Professionals only

By choosing to continue, you are confirming that you are a healthcare professional

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter

Subscribe now
The content of VJOncology is intended for healthcare professionals